Literature DB >> 7050062

Distribution of Ehrlichia canis among military working dogs in the world and selected civilian dogs in the United States.

T J Keefe, C J Holland, P E Salyer, M Ristic.   

Abstract

Antibodies to Ehrlichia canis were detected by indirect immunofluorescence in sera from 233 of 2,077 (11%) military working dogs in various locations throughout the world and from 535 of 938 (57%) civilian dogs in the United States during a 1-year period of study. Overall, E canis infection rates ranged from 13% in the tropical and temperate zones below 45 degrees N to 8% in the cold zone north of 45 degrees N latitude. The highest antibody prevalence rate (24%) was found among a select population of dogs stationed between 40 degrees and 45 degrees north latitude (Japan and Okinawa). The seropositive military dogs did not have clinical signs of ehrlichiosis, thus indicating that the predominant form of infection was subclinical. On the other hand, 216 (23%) of the seropositive civilian dogs had various signs of the disease. The difference was attributed to the fact that the sera from civilian dogs were submitted by practitioners who suspected the disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7050062

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  21 in total

Review 1.  Recent advances in determining the pathogenesis of canine monocytic ehrlichiosis.

Authors:  S Harrus; T Waner; H Bark; F Jongejan; A W Cornelissen
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 2.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

Review 3.  An overview of research on ehrlichiosis.

Authors:  M Ristic; C J Holland; M Khondowe
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

4.  Canine ehrlichiosis in Connecticut.

Authors:  L A Magnarelli; H J Litwin; C J Holland; J F Anderson; M Ristic
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

5.  Epidemiologic and clinical characteristics of persons with serologic evidence of E. canis infection.

Authors:  B W Rohrbach; J R Harkess; S A Ewing; J Kudlac; G L McKee; G R Istre
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

6.  Molecular and antigenic comparison of Ehrlichia canis isolates from dogs, ticks, and a human in Venezuela.

Authors:  A Unver; M Perez; N Orellana; H Huang; Y Rikihisa
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

7.  Comparison of nested PCR with immunofluorescent-antibody assay for detection of Ehrlichia canis infection in dogs treated with doxycycline.

Authors:  B Wen; Y Rikihisa; J M Mott; R Greene; H Y Kim; N Zhi; G C Couto; A Unver; R Bartsch
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

8.  Serodetection of Ehrlichia canis infection in dogs from Ludhiana district of Punjab, India.

Authors:  L D Singla; Harkirat Singh; P Kaur; N D Singh; N K Singh; P D Juyal
Journal:  J Parasit Dis       Date:  2011-08-02

9.  Lack of co-transmission of Rickettsia conorii and Ehrlichia canis in human beings in the south of France.

Authors:  P Brouqui; D Raoult; E Vidor
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

Review 10.  The tribe Ehrlichieae and ehrlichial diseases.

Authors:  Y Rikihisa
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.